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The enzymatically derived and enantiopure cis-1,2-dihydrocatechol 1 has been converted, over 14 one-pot operations, into
the (þ)-form of the alkaloid narseronine (2). The present study, which complements earlier work that established a route
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Introduction
cis-1,2-Dihydrocatechols such as 1 are readily obtained in
enantiomerically pure form (viz. .99.8% ee) through the
whole-cell biotransformation of the corresponding arene
5 (bromobenzene in this case) using mutant forms of bacteria that
produce toluene dioxygenase (TDO), the enzyme responsible
for this fascinating conversion.[1,2] Metabolites such as 1 have
proved to be particularly effective starting materials for
the chemical synthesis of a remarkably diverse range of chiral,
10 non-racemic natural products and/or biologically active com-
pounds.[2] However, an ongoing issue associated with this
(chemoenzymatic[3]) approach to the construction of such target
systems is the seeming confinement of it to the generation of a
single enantiomeric form of a given target molecule.[4] As part
15 of an effort to address such constraints, Hudlicky and his
coworkers demonstrated that the ‘latent’ symmetry elements
associated with compound 1 and certain of its congeners[2a,d]
allow their use in the enantiodivergent synthesis of, inter alia,
cyclitols.[5] Similarly, we have shown that various cis-1,2-
20 dihydrocatechols can participate in a range of Diels–Alder
cycloaddition processes that permit the assembly of either
enantiomeric form of certain polycyclic frameworks, including
those associated with sesquiterpenoid natural products.[6] In a
related vein, we now detail the outcomes of a study that has
25 culminated in the identification of a method for the assembly of
the (þ)-form of the Amaryllidaceae alkaloid narseronine (2)[7]
from compound 1, work that complements our recently reported
synthesis[8] of its optical antipode [viz. ()-narseronine] from
the same starting material (Chart 1).
30 The key features of our previously reported synthesis of
()-narseronine [()-2] involved the initial conversion
(Scheme 1) of metabolite 1 into the well-known derivative 3
(95%),[5] which was itself engaged in selective epoxide ring-
opening on treatment with the anion derived from acetonitrile.
The product alcohol 4 (96%)[9] was then deoxygenated using
the Barton–McCombie protocol[10] so as to afford the bromo-
alkene 5 (82%) that participates in a Suzuki–Miyaura cross-
coupling reaction with the arylboronate 6[9] to give compound 7
5(75%). Various manipulations of this last compound includ-
ing the Raney-cobalt mediated reduction of the associated
nitrile residue[9,11] afforded, over eight steps and in 16% overall
yield, the a-arylated cyclohexenone 8 carrying a protected
secondary amine residue tethered through the g-carbon. Finally,
10treatment of compound 8 with (Ph3P)4Pd in the presence of
dimedone resulted in cleavage of the Alloc group, thus allowing
the resulting secondary amine 9 (which was not isolated) to
undergo an intramolecular hetero-Michael addition reaction/
trans-acylation sequence and thus affording ()-narseronine
15[()-1] (82%), the structure of which was secured by single-
crystal X-ray analysis. Unfortunately, the specific rotation for
the natural product obtained by Bastida et al.[7] was not reported
and so it has not been possible to establish its absolute
configuration.
20Results and Discussion
The synthetic route used to effect the conversion 1 - (þ)-2,
the focus of the study reported herein, relied, in its early stages
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(Scheme 2), on chemistry established during the course of pre-
paring the non-natural enantiomeric form of the alkaloid clivi-
dine.[12] Specifically, diene 1 was treated with N-
bromosuccinimide (NBS) in wet THF, thus generating, in a
5 completely regio- and diastereo-selective manner, bromohydrin
10,[12] which was readily protected as the corresponding acet-
onide 11[12] (92% from 1) under conventional conditions.
Successive treatment of compound 11 with sodium hydride (so
as to form the corresponding epoxide) and then the anion of
10 acetonitrile (which was generated in situ by treating acetonitrile
itself with n-BuLi) afforded the previously reported[12] g-
hydroxynitrile 12 (87%). Conversion of compound 12 into the
corresponding methyl xanthate 13[12] (93%) was achieved
under conventional conditions and this was then subjected to a
Barton–McCombie deoxygenation reaction using tri-n-butyltin
hydride and 2,20-azobis(2-methylpropionitrile) (AIBN) in
refluxing benzene, thus generating the deoxygenated congener
of alcohol 12, viz. compound 14.[12] This was obtained in 87%
5yield. Suzuki–Miyaura cross-coupling of bromoalkene 14 with
the arylboronate 6[9] proceeded smoothly on using PdCl2(dppf)
CH2Cl2 in the presence of triethylamine, thereby providing the
previously reported compound 15[12] in 95% yield.
The chemistry used to complete the synthesis of (þ)-
10narseronine [(þ)-2] is shown in Scheme 3 and began with the
exposure of the Suzuki–Miyaura cross-coupling product 15 to
aqueous acetic acid at 508C such that the allylic hydroxyl group
of the initially formed diol reacted with the proximate ester
residue to afford the lactone 16 (84%).[12] The free hydroxyl
15group within this last compound was protected as the corre-
sponding TBDPS-ether 17[12] (80%) using conventional condi-
tions and this was, in turn, subjected to reaction with dihydrogen
in the presence of Raney-cobalt[13] in ammoniacal methanol
to produce the previously reported primary amine 18 (82%).[12]
20In a pivotal step of the reaction sequence, this last compound
was treated successively with 1.1 molar equivalents of NBS,
then, after 0.5 h, with tri-n-butyltin hydride (n-Bu3SnH) and
AIBN, so affording compound 19 (83%), which now incorpo-
rates the unsaturated B-ring lactone and, therefore, the full
25polycyclic framework of (þ)-narseronine [(þ)-2].
The exact pathway followed during the conversion 18- 19
remains unclear at the present time but it seems likely that the
initial step involves the formation of the N-bromo-derivative
of the former compound (through halogen atom transfer from
30NBS) and that this derivative reacts with n-Bu3SnH to give the
corresponding nitrogen-centred radical, which itself engages in
a 5-exo-trig cyclisation process to give the tetracyclic benzylic
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radical. The precise means by which this last species is con-
verted into the final, alkene-containing product remains to be
determined but it is conceivable that another bromine atom
transfer is involved, thus forming a benzylic bromide that
5 promptly loses the elements of HBr, thereby generating com-
pound 19.
Completion of the synthesis of (þ)-narseronine [(þ)-2] from
compound 19 required inversion of configuration at C5 as well
as N- and O-methylation reactions. The best means of addres-
10 sing the first of these requirements was to cleave the TBDPS
ether residue within the latter compound using tetra-n-butyl-
ammonium fluoride (TBAF) and then oxidising the resulting
alcohol 20 (95%) with MnO2, so forming the ketone 21 (78%).
All the 1H and 13C NMR spectral data acquired on products 20
15 and 21were in complete accord with the assigned structures but
final confirmation of these followed from a single-crystal X-ray
analysis on the former compound. The derivedORTEP is shown
in Fig. 1 and various crystal data are presented in the Experi-
mental section. Treatment of compound 21 with the Luche
20 reagent[14] derived from reacting sodiumborohydride andCeCl3
heptahydrate in methanol resulted in the essentially exclusive
formation of the C5 epimer of compound 20, namely alcohol 22,
which was obtained in 99% yield and the structure of which was
also secured by single-crystal X-ray analysis. Presumably, the
25 stereochemical outcome of this 1,2-reduction process derives
from the steric impositions of the b-orientated pyrrolidine ring
that ensure hydride is delivered to the a-face of the ketone
carbonyl unit.
The necessary N,O-dimethylation of aminoalcohol 22 so as
30 to generate (þ)-narseronine proved to be a remarkably difficult
transformation. So, for example, treatment of the former com-
pound with methyl iodide and silver(I) oxide (no solvent)
afforded a complex mixture of products from which a small
amount of a rather unstable crystalline compound could be
35 obtained. A single-crystal X-ray analysis of this material
established that it was the arene hydrate 24 (Scheme 4).[15] This
presumably arises via a two-fold N-methylation of substrate 22
to produce the methiodide salt 23, which itself fragments in the
illustrated manner to give, after loss of the elements of hydrogen
5iodide, the observed product. Eventually, it was established that
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Fig. 1. ORTEP derived from the single-crystal X-ray analysis of com-
pound 20 (CCDC no. 944982) with labelling of selected atoms. Anisotropic
displacement ellipsoids display 30% probability levels. Hydrogen atoms are
drawn as circles with small radii.
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when a THF solution of compound 22maintained at 0–188Cwas
treated with ,4 molar equivalents of potassium hydride and 8
equivalents of methyl iodide (Scheme 3), then a relatively clean
N,O-bismethylation reaction took place, thus finally providing
5 (þ)-narseronine [(þ)-2] in 83% yield after chromatographic
purification. The 1H and 13C NMR spectral data obtained on
this material matched those recorded earlier[8] for its enantiomer
but final confirmation of its structure (other than absolute
stereochemistry) followed from a single-crystal X-ray analysis.
10 The specific rotation of compound (þ)-2 was þ21.0 (c 0.3,
CDCl3). This compares with the value of 25.4 (c 1.6, CDCl3)
recorded[8] for its enantiomer.
Conclusions
The ability to effect syntheses of both (þ)- and ()-narseronine
15 [(þ)-2 and ()-2, respectively] from the cis-1,2-dihy-
drocatechol 1 serves to further emphasise the utility of such
systems as starting materials in chemical synthesis. In this
instance, the capacity for enantiodivergence arises by virtue of
being able to readily generate the isomeric nitriles 4 and 12, the
20 C6 stereochemistries of which determine the orientations (a or
b) of the derived pyrrolidine or D-rings in the product enan-
tiomers ()-2 and (þ)-2, respectively. In the case of the
reaction sequence leading to the latter form of the title alkaloid,
an inversion of configuration at C5 in compound 19 is required.
25 Despite this, the lengths of the two reaction sequences are
similar (viz. 14 vs 15 steps), not least because of the more
efficient means of introducing the methyl group at nitrogen in
the one reported here. Extensions of the chemistries defined
above to the assembly of both enantiomeric forms of related
30 alkaloids are now being pursued. Results will be reported in
due course.
Experimental
General Experimental Procedures
Unless otherwise specified, proton (1H) and carbon (13C) NMR
35 spectra were recorded at 188C in base-filtered CDCl3 on a
Varian spectrometer operating at 400MHz for proton and
100MHz for carbon nuclei. 1H NMR data are recorded as
follows: chemical shift (d) [multiplicity, coupling constant(s)
J (Hz), relative integral] where multiplicity is defined as:
s¼ singlet; d¼ doublet; t¼ triplet; q¼ quartet; m¼multiplet,
or combinations of the above. The signal due to residual CHCl3
appearing at dH 7.26 and the central resonance of the CDCl3
5‘triplet’ appearing at dC 77.0 were used to reference
1H and 13C
NMR spectra, respectively. Infrared spectra (nmax) were recor-
ded on a Perkin–Elmer 1800 Series Fourier-transform (FT)IR
spectrometer. Samples were analysed as thin films on KBr
plates. Low-resolution electrospray ionisation (ESI) mass
10spectra were recorded on a Micromass LC-ZMD single quad-
rupole liquid chromatograph–mass spectrometer whereas high-
resolution measurements were conducted on an LCT Premier
time-of-flight instrument. Low- and high-resolution EI mass
spectra were recorded on an Autospec Premier Micromass
15magnetic-sector machine. Optical rotations were recorded in
CHCl3 at 208C on a Perkin–Elmer Model 343 polarimeter using
a cell of 1 dm in length. Melting points were measured on an
Optimelt automated melting point system and are uncorrected.
Analytical thin-layer chromatography (TLC) was performed on
20aluminium-backed 0.2-mm thick silica gel 60 F254 plates as
supplied byMerck. Eluted plates were visualised using a 254 nm
UV lamp and/or by treatment with a suitable dip followed by
heating. These dips included phosphomolybdic acid/ceric
sulfate/sulfuric acid (conc.)/water (37.5 g : 7.5 g : 37.5 g :
25720mL) or potassium permanganate/potassium carbonate/5%
sodium hydroxide aqueous solution/water (3 g : 20 g : 5mL :
300mL). Flash chromatographic separations were carried out
following protocols defined by Still et al.[16] with silica gel 60
(40–63 mm) as the stationary phase and using the AR- or HPLC-
30grade solvents indicated. Starting materials and reagents were
generally available from the Sigma–Aldrich, Merck, TCI,
Strem or Lancaster chemical companies and were used as sup-
plied. Drying agents and other inorganic salts were purchased
from the AJAX, BDH or Unilab Chemical Companies. Tetra-
35hydrofuran (THF), methanol, and dichloromethane (DCM)
were dried using a Glass Contour solvent purification system
that is based on a technology originally described by Grubbs
et al.[17] Where necessary, reactions were performed under an
argon atmosphere.
40Specific Synthetic Transformations
(3aS,5S,12cS)-5-[(tert-Butyldiphenylsilyl)oxy]-
2,3,3a,4,5,12c-hexahydro-[1,3]-dioxolo-[40,50:6,7]
isochromeno[3,4-g]indol-7(1H)-one (19)
A magnetically stirred solution of amine 18[12] (300mg,
450.55mmol) in degassed benzene (20mL) maintained at 188C
under an atmosphere of nitrogen was treated, in portions, with
NBS (108mg, 0.61mmol, 1.1mol equiv.). After a further 0.5 h,
the reaction mixture was placed in an oil bath heated at 858C,
then treated, via syringe pump over 0.83 h, with a solution of
50tri-n-butyltin hydride (194 mL, 0.72mmol, 1.3mol equiv.) and
AIBN (11.5mg, 0.07mmol, 0.13mol equiv.) in benzene
(5mL). After a further 2 h, the ensuing mixture was cooled to
188C, then concentrated under reduced pressure. The resulting
orange oil was subjected to flash chromatography (silica,
552%v/v ammonia-saturatedmethanol/dichloromethane elution).
Concentration of the appropriate fractions (Rf 0.4) gave com-
pound 19 (246mg, 83%) as white foam, [a]D
20 3.95 (c 1.0,
CHCl3). Found:m/z 540.2206 (MþH)þ; C32H33NO5Si requires
540.2206 (MþH)þ. dH (400MHz, CDCl3) 7.75–7.65 (complex
60m, 4H), 7.48–7.21 (complex m, 8H), 6.04 (m, 2H), 4.42 (t,
J 3.0, 1H), 3.96 (d, J 6.0, 1H), 3.20 (m, 1H), 3.05 (m, 1H), 2.88
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(m, 1H), 2.19 (m, 1H), 1.71 (m, 1H), 1.53 (m, 2H), 1.06 (s, 9H)
(signal due to N–H group proton not observed). dC (100MHz,
CDCl3) 160.9 153.7 151.9 148.2 135.9(1), 135.8(7), 134.8,
133.8, 133.2, 129.7(1), 129.6(5), 127.7, 127.5, 116.3, 111.2,
5 107.3, 103.5, 102.2, 66.7, 56.6, 46.2, 33.7, 32.7, 31.4, 27.0, 19.4.
nmax (KBr)/cm
1 2929, 2856, 1716, 1503, 1482, 1416, 1254,
1111, 1070, 1035, 937, 762. m/z (ESI, þve) 562 ([M þ Na]þ,
6%), 540 ([M þ H]þ, 50), 267 (100).
(3aS,5S,12cS)-5-Hydroxy-2,3,3a,4,5,12c-hexahydro-
10 [1,3]dioxolo[40,50:6,7]-isochromeno[3,4-g]indol-
7(1H)-one (20)
A magnetically stirred solution of compound 19 (215mg,
0.4mmol) in THF (40mL) maintained under an atmosphere
of nitrogen was cooled to 08C, then treated with tetra-n-
15 butylammonium fluoride (0.8mL of a 1M solution in THF,
0.8mmol, 2.0mol equiv.). The ensuing mixture was warmed to
188C, stirred at this temperature for 18 h, then quenched with
sodium bicarbonate (5mL of a saturated aqueous solution) and
diluted with DCM (3 10mL). The combined organic extracts
20 were washed with brine (3 10mL) before being dried
(Na2SO4), filtered, and concentrated under reduced pressure to
afford a light-yellow oil. Subjecting this material to flash
chromatography (silica, 4% v/v ammonia-saturated methanol/
dichloromethane) and concentration of the appropriate fractions
25 (Rf 0.4) gave compound 20 (114mg, 95%) as white, crystalline
solid, mp 1638C. [a]D
20 þ82.5 (c 1.0, CHCl3). Found: m/z
302.1027 (M þ H)þ; C16H15NO5 requires 302.1028 (M þ H)þ.
dH (400MHz,CDCl3) 7.33 (s, 1H), 7.17 (s, 1H), 6.06 (s, 1H), 6.03
(s, 1H), 4.43 (s, 1H), 3.76 (d, J 6.0, 1H), 3.25 (m, 1H), 3.01
30 (m, 1H), 2.69 (m, 1H), 2.13 (m, 1H), 1.90–1.71 (complexm, 2H),
1.59 (m, 1H) (signals due to N–H and O–H group protons
not observed). dC (100MHz, CDCl3) 161.3, 153.7, 152.3,
148.1, 134.6, 115.6, 110.9, 107.1, 103.3, 102.3, 64.3, 56.4,
46.1, 32.7, 32.5, 31.2. nmax (KBr)/cm
1 3416, 3330, 2927,
35 1706, 1654, 1502, 1483, 1418, 1282, 1255, 1115, 1037. m/z
(ESI, þve) 324 ([M þ Na]þ, 13%) 302 ([M þ H]þ, 22), 267
(100), 242 (60), 241 (48).
(3aS,12cS)-1,2,3,3a,4,12c-Hexahydro-[1,3]dioxolo
[40,50:6,7]isochromeno[3,4-g]indole-5,7-dione (21)
40 Manganese dioxide (455mg, 5.2mmol, 15mol equiv.) was
added in one portion to amagnetically stirred solution of alcohol
20 (105mg, 0.35mmol) in DCM (25mL). The ensuing mixture
was heated to 308C for 22 h while being maintained under a
nitrogen atmosphere, then cooled to 188C before being filtered
45 through a pad of CeliteTM. The filtrate was concentrated under
reduced pressure and the resulting brown oil subjected to flash
chromatography (silica, ,2–3% v/v ammonia-saturated meth-
anol/dichloromethane). Concentration of the appropriate frac-
tions (Rf 0.5) gave compound 21 (81mg, 78%) as a white solid,
50 mp 142–1438C. [a]D
20 þ88.8 (c 1.0, CDCl3). Found: m/z
300.0871 (M þ H)þ; C16H13NO5 requires 300.0872 (M þ
H)þ. dH (400MHz, CDCl3) 7.67 (s, 1H), 7.42 (s, 1H), 6.16
(m, 2H), 4.30 (d, J 4.0, 1H), 3.32 (m, 1H), 3.15 (m, 1H), 2.90
(m, 1H), 2.73–2.62 (complex m, 2H), 2.20 (m, 1H), 1.84 (broad
55 s, 1H), 1.71 (m, 1H). dC (100MHz, CDCl3) 188.7, 159.3, 153.9,
150.5, 143.1, 132.5, 124.6, 119.3, 108.3, 104.7, 102.8, 56.0,
46.2, 39.3, 37.4, 31.5. nmax (KBr)/cm
1 3349, 2931, 2876, 1714,
1677, 1501, 1484, 1416, 1322, 1274, 1254, 1145, 1026. m/z
(ESI,þve) 621 ([2Mþ Na]þ, 77%), 599 ([2Mþ H]þ, 99), 322
60 ([M þ Na]þ, 46), 300 ([M þ H]þ, 80), 283 (100).
(3aS,5R,12cS)-5-Hydroxy-2,3,3a,4,5,12c-hexahydro-
[1,3]dioxolo[40,50:6,7]-isochromeno[3,4-g]indol-
7(1H)-one (22)
A magnetically stirred solution of ketone 21 (73mg,
50.25mmol) and CeCl37H2O (92mg, 0.38mmol, 1.5 equiv.) in
methanol (10mL)was cooled to788C and, after 0.25 h, treated
with sodium borohydride (11.3mg, 0.03mmol, 1.2mol equiv.)
then, after 0.03 h, with sodium bicarbonate (2mL of a saturated
aqueous solution). The resulting mixture was extracted with
10dichloromethane (5 10mL), the combined organic phases
were dried (MgSO4), filtered, and concentrated under reduced
pressure, with the residue thus obtained being subjected to flash
chromatography (silica, 96 : 4 v/v dichloromethane/ammonia-
saturated methanol). Concentration of the appropriate fractions
15(Rf 0.4) gave compound 22 (73mg, 99%) as a white, crystalline
solid, mp 168–1698C. [a]D
20 þ83.9 (c 1.0, CDCl3). Found: m/z
302.1031 (M þ H)þ; C16H15NO5 requires 302.1028 (M þ H)þ.
dH (400MHz, CDCl3) 7.57 (s, 1H), 7.34 (s, 1H), 6.10 (m, 2H),
4.65 (dd, J 12.0, 6.0, 1H), 3.86 (d, J 3.0, 1H), 3.32 (m, 1H), 3.05
20(m, 1H), 2.43 (m, 1H), 2.15–2.02 (complex m, 3H), 1.78–1.63
(complex m, 2H) (signal due to N–H group proton not
observed). dC (100MHz, CDCl3) 161.3, 154.1, 152.6, 148.2,
135.0, 115.3, 107.4, 103.5, 102.3, 65.9, 57.1, 46.0, 35.7, 33.1,
31.8 (one signal obscured or overlapping). nmax (KBr)/cm
1
253316, 2926, 2870, 1709, 1621, 1502, 1481, 1416, 1283, 1256,
1165, 1094, 1034. m/z (ESI, þve) 324 ([M þ Na]þ, 40%) 302
([M þ H]þ, 100), 241 (35).
(R)-2-(2-(Dimethylamino)ethyl)-4-hydroxy-3,
4-dihydro-6H-[1,3]dioxolo[40,50:4,5]benzo-[1,2-c]
30chromen-6-one (24)
A magnetically stirred mixture of compound 22 (42mg,
0.14mmol) and methyl iodide (1mL, 16mmol) maintained
under a nitrogen atmosphere at 188C was treated with silver(I)
oxide (323mg, 1.4mmol) and the resulting mixture stirred in a
35sealed tube at 508C for 16 h before being cooled, filtered, and
concentrated under reduced pressure. The resulting yellow oil
was subjected to flash chromatography (silica, 95 : 5- 90 : 10
v/v dichloromethane/ammonia-saturated methanol gradient
elution) and concentration of the relevant fractions (Rf 0.3 in
4090 : 10 v/v dichloromethane/ammonia-saturatedmethanol) gave
an unstable oil (30mg), a portion of which crystallised on
standing. A crystal of this material was subjected to single-
crystal X-ray analysis and this revealed it to be compound 24.
The very small quantities of compound 24 obtained by this
45means precluded the acquisition of any other spectral data.
(3aS,5R,12cS)-5-Hydroxy-2,3,3a,4,5,12c-hexahydro-
[1,3]dioxolo-[40,50:6,7]isochromeno[3,4-g]indol-
7(1H)-one [(þ)-2, (þ)-Narseronine]
A magnetically stirred solution of alcohol 22 (18.6mg,
500.06mmol) in dry THF (2mL) maintained at 08C under a
nitrogen atmosphere, was treated, in portions, with potassium
hydride (32mg of a 30% dispersion in mineral oil, 0.24mmol,
4.0mol equiv.) and then with methyl iodide (30mL, 0.48mmol,
8.0mol equiv.) After a further 4 h, the reaction mixture was
55quenched with NH4Cl (2mL of a saturated aqueous solution)
and the separated aqueous phase extracted with dichloromethane
(3 10mL). The combined organic phaseswere dried (Na2SO4),
filtered, and concentrated under reduced pressure. The light-
yellow oil thus obtained was subjected to flash chromatography
60(silica, 95 : 5 v/v, dichloromethane/ammonia-saturated methanol
A Chemoenzymatic Synthesis of (þ)-Narseronine E
PR
OO
F
ON
LY
elution) and concentration of the appropriate fractions (Rf 0.4)
gave (þ)-narseronine [(þ)-2] (16.8mg, 83%) as a white,
crystalline solid, mp 165–1668C [lit.[8] for ()-enantiomer
167–1688C]. [a]D
20 þ21.0 (c 0.3, CHCl3). Found: m/z 330.1342
5 (M þ H)þ; C18H19NO5 requires 330.1341 (M þ H)þ. dH
(400MHz, CDCl3) 7.67 (s, 1H), 7.28 (s, 1H), 6.13 (m, 2H),
4.22 (t, J 6.0, 1H), 3.82 (broad s, 1H), 3.57 (s, 3H), 3.07 (m, 1H),
2.78 (m, 1H), 2.64 (m, 1H), 2.44 (s, 3H), 2.25–2.10 (complex m,
2H), 2.01 (m, 1H), 1.90 (m, 1H). dC (100MHz, CDCl3) 161.5,
10 153.7, 152.7, 148.3, 135.2, 116.4, 108.5, 107.8, 103.3, 102.4,
75.0, 62.0, 58.2, 54.3, 42.1, 35.0, 31.4, 29.5. nmax (KBr)/cm
1
3449, 2927, 1718, 1623, 1502, 1482, 1413, 1282, 1256, 1161,
1102, 1035. m/z (ESI, þve) 352 ([M þ Na]þ, 8%), 330 ([M þ
H]þ, 100), 298 (20). The 1H NMR, 13C NMR, and infrared
15 spectral data presented above were in good agreement with
those reported for the natural product[7] and for the synthetically
derived ()-narseronine.[8] The only minor discrepancy was
observed in the 13C NMR spectra. In particular, the signal
reported at 111.5 ppm in the spectrum of the synthetically
20 derived ()-enantiomer was replaced by one at 108.5 ppm in
that of (þ)-2. This difference is attributed to the differing
acidities of the media in which the samples were analysed.
X-Ray Crystallographic Study
Crystallographic Data
25 Compound (1)-2
C18H19NO5, M 329.35, T 150K, tetragonal, space group
P41212, Z 8, a 9.0508(2), b 9.0508(2), c 38.9156(17) A˚, V
3187.85(17) A˚3, Dx 1.372 g cm
3, 3137 unique data (2ymax
1468), R 0.063 [for 2832 reflections with I. 2.0s(I)], Rw
30 0.135 (all data), S 1.04.
Compound 20
3(C16H15NO5)CH2Cl2CH4O, M 1020.87, T 200K, mono-
clinic, space group P21, Z 2, a 10.4126(15), b 14.0062(19), c
15.8996(18) A˚,b 103.807(8)8,V 2251.8(5) A˚3,Dx 1.506 g cm
3,
35 4142 unique data (2ymax 50.28), R 0.102 [for 2507 reflections
with I. 2.0s(I)], Rw 0.285 (all data), S 1.01.
Compound 22
C16H15NO5, M 301.30, T 200K, orthorhombic, space group
P212121, Z 4, a 7.2115(2), b 12.2738(3), c 14.9955(5) A˚, V
40 1327.29(7) A˚3, Dx 1.508 g cm
3, 1764 unique data (2ymax 558),
R 0.035 [for 1543 reflections with I. 2.0s(I)], Rw 0.084 (all
data), S 0.99.
Compound 24
C18H19NO5, M 329.35, T 200K, orthorhombic, space group
45 P212121, Z 4, a 7.9212(7), b 8.8428(8), c 22.4138(19) A˚, V
1570.0(2) A˚3, Dx 1.393 g cm
3, 1615 unique data (2ymax 508),
R 0.064 [for 1109 reflections with I. 2.0s(I)], Rw 0.137 (all
data), S 1.08.
Structure Determination
50 Images were measured on a Nonius Kappa CCD diffractometer
(MoKa, graphite monochromator, l 0.71073 A˚) and data
extracted using the DENZO package[18] or an Agilent Super-
Nova CCD diffractometer (CuKa, mirror monochromator, l
1.54184 A˚) and data extracted using the CrysAlis package.[19]
55 Structure solutions were by direct methods (SIR92).[20] The
structures of compounds (þ)-2, 20, 22, and 24 were refined
using the CRYSTALS program package.[21] Atomic coordinates,
bond lengths and angles, and displacement parameters have
been deposited at the Cambridge Crystallographic Data Centre
(CCDC nos. 1020370, 944982, 948651, and 1017935 for com-
5pounds (þ)-2, 20, 22, and 24, respectively). These data can be
obtained free of charge via www.ccdc.cam.ac.uk/data_request/
cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting
The Cambridge Crystallographic Data Centre, 12 Union Road,
Cambridge CB2 1EZ, UK; fax: þ44 1223 336033.
10Supplementary Material
The anisotropic displacement ellipsoid plots derived from the
single-crystal X-ray structures of compounds (þ)-2, 20, 22, and
24 together with 1H and 13C NMR spectra of compounds (þ)-2,
19, 20, 21, and 22 are available on the Journal’s website.
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